Zhiyun Health (09955) reached a high of nearly 13%. As of press release, it rose 8.82% to HK$2.96, with a turnover of HK$56.5093 million.
The Zhitong Finance App learned that Zhiyun Health (09955) had the highest increase of nearly 13%. As of press release, it had risen 8.82% to HK$2.96, with a turnover of HK$56.5093 million.
According to the news, Zhiyun Health's 2023 financial report shows that the company achieved revenue of 3.69 billion yuan last year, an increase of 23.5% over the previous year. Among them, in-hospital solution revenue was 2.87 billion yuan, accounting for more than 70%. It was the largest source of revenue, with a year-on-year increase of 31.5%. Non-IFRS (non-IFRS) adjusted net loss narrowed to 75.1 million yuan, a year-on-year decrease of 77.4%. The fourth quarter became the company's first profitable quarter, turning losses into profits in a single quarter.
CICC pointed out that the company's in-house solutions are growing steadily and exploring the P2M development model. In 2023, P2M contributed approximately $100 million in revenue from in-hospital solutions. Pharmacy Solution's revenue in 2023 increased 6.9% year-on-year to 660 million yuan. Management publicly stated that the company's resource investment in 2023 will focus on the hospital sector, and it is expected that the P2M business will gradually expand into the pharmacy sector starting in 2024.